TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Beactica Therapeutics AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
666
|
660
|
437 |
| Financial expenses |
10
|
10
|
14 |
| Earnings before taxes |
-813
|
-957
|
-997 |
| EBITDA |
-788
|
-929
|
-931 |
| Total assets |
2,701
|
3,280
|
2,771 |
| Current assets |
385
|
1,157
|
648 |
| Current liabilities |
213
|
388
|
474 |
| Equity capital |
2,444
|
2,798
|
2,122 |
| - share capital |
32
|
30
|
29 |
| Employees (average) |
9
|
8
|
8 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
90.5%
|
85.3%
|
76.6% |
| Turnover per employee |
74
|
82
|
55 |
| Profit as a percentage of turnover |
-122.1%
|
-145.0%
|
-228.1% |
| Return on assets (ROA) |
-29.7%
|
-28.9%
|
-35.5% |
| Current ratio |
180.8%
|
298.2%
|
136.7% |
| Return on equity (ROE) |
-33.3%
|
-34.2%
|
-47.0% |
| Change turnover |
4
|
258
|
149 |
| Change turnover % |
1%
|
64%
|
52% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
13%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.